#United States #New York #Securities Fraud #Rosen Law Firm #Picard Medical

PMI Investors Given Chance to Lead Lawsuit Against Picard Medical

Overview

The Rosen Law Firm, renowned for its commitment to investor rights, has issued an important reminder for those who purchased Picard Medical, Inc. securities on NYSE American ( PMI ) between September 2, 2025, and October 31, 2025. Those affected are welcomed to partake in a class action lawsuit aimed at holding the company accountable for alleged securities fraud. The filing deadline for lead plaintiffs is April 13, 2026.

Details of the Class Action

If you are among those who invested in Picard Medical during the specified timeframe, you might be entitled to recuperate your losses without incurring upfront legal expenses through a contingency fee agreement. To participate, one can visit Rosen Law Firm's website or contact Phillip Kim, Esq. via phone or email for more insights about the class action suit.

The lawsuit underscores that a class has yet to be certified. Therefore, until that occurs, investors are not represented unless they seek their counsel, and remaining passive as class members is also an option.

The Allegations

The allegations against Picard Medical include a range of serious breaches. According to the lawsuit, the defendants are accused of making deliberately misleading statements and failing to disclose significant adverse facts regarding the company's operations and the true nature of its securities trading throughout the defined period. Key aspects of the allegations include:

1. Fraudulent Stock Promotion: Picard Medical purportedly became embroiled in a fraudulent stock promotion scheme that operated via misleading social media narratives and impersonation of financial professionals.
2. Insider Trading Activities: Reports claim that insiders utilized offshore or nominee accounts to facilitate the coordinated offloading of shares concurrent with a price inflation strategy.
3. Omission of Material Risk: The disclosures from the company reportedly omitted significant mentions of false rumors and artificial trading activities that influenced its stock price.
4. Misleading Statements: As a result of the aforementioned issues, positive statements made by the company regarding its operational performance and future prospects were materially misleading and lacked sound justification.

Importance of Qualified Legal Representation

The Rosen Law Firm emphasizes the necessity for investors to choose experienced legal counsel with a proven track record for success in leading roles within securities class actions. Many legal notices do not stem from firms with sufficient experience and resources and may only act as intermediaries without genuine litigation involvement.

Rosen Law Firm boasts a history of successful settlements in securities class actions, including the largest against a Chinese company at that time and multiple years of high rankings for settlement recoveries. With hundreds of millions of dollars secured for investors, the firm’s reputation continues to grow, alongside accolades bestowed upon its attorneys for their advocacy.

Joining the Class Action

Interested parties can now join the Picard Medical class action by navigating to the provided form linked earlier or by reaching out for clarification on the process. All potential lead plaintiffs must take action by the April 13 deadline to proceed as representative parties in court.

For updates on this case, the Rosen Law Firm can be followed on various social media platforms including LinkedIn, Twitter, and Facebook, providing continuous communication to all interested investors on the evolving situation.

While this represents a sobering opportunity for those who believed in Picard Medical’s potential, navigating the complexities of securities fraud lawsuits requires informed decision-making and prompt action. Investors are encouraged to consider their options carefully as they determine their paths forward in this unfolding saga.